Investigation Launched into Alignment Healthcare Following Disappointing Q2 Results and Whistleblower Claims

Alignment Healthcare Under Scrutiny: A Call to Investors

In the wake of a significant decline in stock value, Alignment Healthcare, Inc. (NASDAQ: ALHC) is facing an intensified investigation spearheaded by the law firm Hagens Berman Sobol Shapiro LLP. The firm is reaching out to investors who have experienced considerable financial losses following the company's disappointing second-quarter results and recent whistleblower allegations that have raised alarms about the company’s financial practices.

Context of the Investigation

On July 30, 2026, Alignment Healthcare released its financial report which was met with unfavorable reactions from investors, leading to a sharp decline in its stock price—down nearly 45% over the past month. The report revealed a major strategy shift as Alignment announced plans to reinvest its earnings into clinical infrastructure and market expansion strategies for the upcoming years. While such plans may bear fruit in the long run, they resulted in lower guidance for near-term profitability, with only 30% of the full year’s adjusted EBITDA expected in the second half—a notable fall from 40% in the prior year.

Whistleblower Allegations

The situation has further been complicated by alarming allegations from a whistleblower. This individual, who holds previous title as the Chief Transformation Officer and was employed by Alignment from 2019 until 2025, claims that the company misclassified operating expenses as capital expenditures. Such actions may have artificially boosted the company’s reported adjusted EBITDA for the years 2024 and 2025. The implications of these claims are severe, as they could not only mislead investors about the true financial status of the company but also inflate executive compensation metrics linked to inflated performance indicators.

Investor Takeaways

In light of these developments, Hagens Berman urges investors with substantial losses in Alignment Healthcare securities to act quickly. The firm is currently evaluating possible violations of securities laws that may have occurred due to misleading representations made by the company. Investors are encouraged to seek legal recourse and explore options available for recovery of losses.

How to Get Involved

If you believe you are a victim of this situation and purchased or acquired Alignment Healthcare securities, you can reach out to Hagens Berman for assistance. They can provide guidance on your legal rights and the avenues available for potential recovery. Investors can contact the firm by visiting hbsslaw.com/investor-fraud/alhc, calling 844-916-0895, or emailing [email protected].

Additionally, whistleblowers who possess non-public information relating to Alignment Healthcare have the opportunity to provide details that could aid in the ongoing investigation. Under the SEC Whistleblower program, individuals could be eligible for rewards amounting to up to 30% of any successful recovery.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is a prominent plaintiff's rights law firm dedicated to holding corporations accountable for their actions. With a track record of over $2.9 billion secured through various litigation efforts, the firm is renowned for representing the interests of whistleblowers, consumers, investors, and others who have faced corporate negligence. The firm continues to operate with a commitment to uncovering truth and providing restitution to those affected.

Investors and whistleblowers are reminded of the importance of swift action in protecting their rights and potential financial recovery amid ongoing investigations into corporate practices.